BioSpace News Archive

Business

Dr. Douglas formerly served as the Senior Vice President of Corporate Development and Corporate Officer at Genzyme Corporation from 1989 until Genzyme was acquired by Sanofi in 2011.

February 13, 2018

·

3 min read

BioForest

CTI BioPharma Announces Closing of Underwritten Public Offering of Common Stock

The expected proceeds to CTI BioPharma from the offering are approximately $64.2M.

February 13, 2018

·

5 min read

Pharm Country

Newron Supports Global Rare Disease Day 2018 and Rett Syndrome Studies

Observed on February 28, Rare Disease Day helps raise awareness of rare diseases, and in turn improve access to treatments.

February 13, 2018

·

8 min read

Genetown

CureVac to Pursue Innovative mRNA Vaccines Against Flu and Malaria

CureVac today announced the awarding of two new grants from the Bill & Melinda Gates Foundation.

February 13, 2018

·

4 min read

Business

Charles River Laboratories Announces Fourth-Quarter and Full-Year 2017 Results from Continuing Operations and Provides 2018 Guidance

For the quarter, revenue from continuing operations was $478.5 million, an increase of 2.5% from $466.8 million in the fourth quarter of 2016.

February 13, 2018

·

33 min read

Business

Charles River Laboratories Announces Executive Management Appointments

Dr. Davide Molho will become President and Chief Operating Officer of Charles River, effective immediately, and will add Discovery Services to his responsibilities.

February 13, 2018

·

6 min read

Business

Q BioMed Adds Big Pharma Executive to Board of Directors

Q Biomed is pleased to welcome Dr. Rick Panicucci as an independent member on its board of Directors.

February 13, 2018

·

3 min read

Business

Aptinyx Appoints Ashish Khanna CFO and CBO

Mr. Khanna has served as chief business officer of Aptinyx since the company’s inception in 2015.

February 13, 2018

·

3 min read

Business

BioLife Solutions Executes OEM Agreement With MilliporeSigma

BioLife Solutions today announced that it has executed an OEM agreement to supply its CryoStor cell freeze media and HypoThermosol cell storage and shipping media under private label to MilliporeSigma, the life science business of Merck KGaA, Darmstadt, Germany.

February 13, 2018

·

4 min read

Drug Development

Trovagene Announces Activation of Two Additional Clinical Trial Sites to Conduct its Phase Ib/II Study of PCM-075 in Patients With AML

The trial, which is being led by hematologist Jorge Cortes, M.D., Deputy Department Chair, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, will be conducted at 10 sites throughout the U.S. and is expected to enroll approximately 74 patients.

February 13, 2018

·

8 min read